GEN-MKT-18-7897-A
Feb 13, 2024 | Blogs, LC, Pharma, QTRAP / Triple Quad, ZenoTOF 7600 system | 0 comments
Read Time: 3 minutes
Managing metabolite identification (Met ID) studies is challenging, so what is at the top of your priority list as you plan the year ahead? Ensuring you have the data needed to manage product safety, meeting deadlines, staff recruitment and training, maintaining compliance, capital expenses, or something else?
At SCIEX, we aim to design solutions that solve these real-world challenges, to make the process more efficient. Imagine the advantages of unambiguous metabolite identification by liquid chromatography-mass spectrometry (LC-MS), even for challenging analytes such as phase II confirmation of glucuronide metabolites.
Manage product safety
Help ensure product safety with complete structural elucidation—even for challenging analytes such as phase II metabolites—with electron activated dissociation (EAD). The ZenoTOF 7600 system can collect EAD and collision-induced dissociation (CID) MS/MS spectra in a single LC-MS/MS experiment.
Meet deadlines
Robust and reliable instruments allow for predictable scheduling and on-time project completion. When needed, our systems are supported by highly respected services and backed by the SCIEX Now support network to ensure that service calls are quickly reported and tracked.
Efficient staff recruitment and training
Streamline new-hire training with knowledge-base articles available on demand from the SCIEX Now Learning Hub. SCIEX OS software is designed to be easy to learn and use for data collection, processing and reporting within a single platform.
Regulatory requirements
SCIEX OS software is compliant-ready to help ease the burden of regulatory activities, including managing user access levels and to reduce the potential for human error.
Capital expense
Invest only in what you need, so you don’t have to spend money on features and system performance that are unnecessary for your samples.
Routine metabolite identification
Larger batches of samples with analytes that typically fragment well using collision-induced dissociation (CID) enable confident identification of the site of metabolism without additional confirmatory testing. In this situation where priorities are typically ease of use and a robust system that does the job day in and day out, SCIEX recommends using the ExionLC AE system coupled to the X500R QTOF system, SCIEX OS software and maintenance with SCIEX service and support.
The workflow described in the technical note Rapid soft spot analysis using a routine biotransformation solution (sciex.com) demonstrates the performance you can expect from this system.
Complex metabolite identification
When clear identification of the site of metabolism is not possible using CID, a secondary analytical technique, such as nuclear magnetic resonance (NMR), is often required to meet regulatory requirements. Since this approach can be both time-consuming and expensive, an LC-MS system with more analytical power is ideal.
The ZenoTOF 7600 system offers electron activated dissociation (EAD) as a complementary fragmentation option to CID. EAD typically fragments the metabolite in different locations, which can provide the additional information required for clear identification of the site of metabolism from a single analytical technique.
SCIEX recommends using the ExionLC AE system coupled to the ZenoTOF 7600 system, SCIEX OS software and maintenance with SCIEX service and support.
The workflow described in the technical note Enhanced drug metabolite identification using collision induced dissociation (CID) and electron-activated dissociation (EAD) (sciex.com) is a useful example of this solution.
Learn more
For more information on the options SCIEX offers for Met ID, please speak to your account manager or visit our web page on Comprehensive Metabolite Identification | SCIEX
The Echo® MS+ system is a novel platform for Acoustic Ejection Mass Spectrometry (AEMS) and combines the speed of acoustic sampling with the selectivity of mass spectrometry. This platform has been designed for high throughput analysis of small and large molecules. The technology combines Acoustic Droplet Ejection (ADE), an Open Port Interface (OPI) and could be coupled with the SCIEX Triple Quad 6500+ system or the ZenoTOF 7600 system.
The Echo® MS+ system comprises of an open-port interface (OPI) and acoustic droplet ejection (ADE) module which could be coupled with a mass spectrometer. The mass spectrometer could either be a SCIEX Triple Quad 6500+ system or the ZenoTOF 7600 system. This non-liquid chromatography based; high-throughput screening platform enables rapid analysis of compounds at speeds of up to 1 sample/second.
The ability to consistently achieve reproducible results on many complex samples across multiple days is critical to a routine clinical laboratory. Laboratories relying on analytical instrumentation require stability and robustness to perform a variety of screening and confirmatory assays with confidence. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) has become the preferred analytical method in the clinical laboratory to reliably perform clinical testing as it provides best-in-class performance and reliability for the most challenging assays. LC-MS/MS offers the required levels of sensitivity and specificity for the detection and quantitation of molecules from complex biological samples, helping laboratories deliver highly accurate data for a variety of clinically relevant analytes across a wide range of assays.
Posted by
You must be logged in to post a comment.
Share this post with your network